Ironwood Pharmaceuticals Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$122,060	$85,239	$41,143	$90,545
Gross Profit	122,060	85,239	13,711	90,545
EBITDA	76,929	46,645	-10,070	33,394
EBIT	76,454	46,178	-10,549	32,909
Net Income	40,080	23,599	-37,386	2,256
Net Change In Cash	122,060	85,239	41,143	90,545
Free Cash Flow	47,581	-15,070	19,923	15,214
Cash	140,407	92,852	108,481	88,559
Basic Shares	177,764	161,723	160,974	160,419

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$351,410	$442,735	$410,596	$413,753
Gross Profit	343,858	436,587	409,178	343,348
EBITDA	97,728	197,411	261,438	233,738
EBIT	95,717	195,836	260,020	232,215
Net Income	880	-1,002,239	175,065	528,448
Net Change In Cash	351,410	442,735	410,596	413,753
Cost of Revenue			36,074	257,080
Free Cash Flow	103,407	183,154	273,627	261,630
Cash	88,559	92,154	656,203	620,129
Basic Shares	160,084	155,435	186,312	164,418